Current approaches to therapy of ALK-positive non-small cell lung cancer

This article analyzes approaches of the treatment of ALK-positive non-small cell lung cancer (NSCLC). Despite the relatively small percentage of patients with ALK-gene rearrangements, identification of this mutation is very important. The most effective treatment for patients with ALK translocation...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: К. К. Laktionov, S Yu. Kruteleva, Е. V. Reutova
Formato: Artigo
Idioma:Russo
Publicado em: Remedium Group LLC 2021-06-01
Colecção:Медицинский совет
Assuntos:
non-small cell lung cancer
alk translocation
alk inhibitors
resistance
crizotinib
lorlatinib
ceretinib
alectinib
brigatinib
Acesso em linha:https://www.med-sovet.pro/jour/article/view/6207
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados